Diligence memo · auto-generated · as of July 2, 2026
Stocosil Inc.
Stocosil Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Stocosil Inc. operates in Pharmaceuticals, based in City of Industry.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Stocosil Inc. has raised $3.0M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $1.0M on 2015-02-20.
Most recent recorded round closed around 2016-04-01.
Valuation (modeled)modeled
Provath models Stocosil Inc. at approximately $27M (range $317K–$304M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.41× the median modeled value of Pre-Seed Pharmaceuticals companies in 2016–2018 (56 peers) — value vs value, same stage and era. Within the normal band (141% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 5 months.
Last raise 10.2 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 35% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 32% of those peers.
Closest niche peers: Essentia Pharma Socal, Llc, Essentia Pharma Florida, Llc, Novellus LLC, Blake Insomnia Therapeutics, Inc., Eleusis Benefit Corporation, PBC.
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.